First China Pharmaceutical (FCPG) Inactive 10-Q2012 Q2 Quarterly report

Filed: 20 Aug 12, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	8th grade Avg

New words: accrual, amid, bureau, ceiling, certificate, certification, certifying, chromium, cleared, condensed, correct, corrected, critical, difficult, diligently, discovered, EFP, employing, exemption, factor, fairly, FIE, fluctuation, footnote, frequently, fully, guarantor, Hengan, herb, herbal, incorrect, incorrectly, Lastly, lending, leveraging, LLP, main, manufacturer, omitted, overstated, overstatement, owed, platform, prepay, prime, promulgated, provision, range, raw, reconstruction, released, relieved, request, restated, restatement, Rotenberg, safety, scale, Section, selection, seventy, SFDA, sixty, small, source, space, thereunder, treatment, treaty, vi, withholding

Removed: accounted, acquirer, acquisition, adverse, agent, amortization, amortized, analyze, appointment, approved, approximate, Article, assist, biochemistry, biological, bring, bringing, broadening, broader, build, bulk, capacity, capitalized, carry, carrying, charged, chemical, classified, comprising, computation, computed, continuing, contracting, depreciation, development, distributor, division, enacted, experience, expert, exposed, facility, familiar, fell, fill, force, founded, free, funding, guarantee, hedging, impairment, improved, indexed, lapse, leasing, located, location, Manual, member, move, negotiated, noted, objective, office, omission, ordering, ordinary, original, physical, predecessor, prominence, properly, purpose, realizable, realized, recent, record, recovered, reduce, regional, replacement, research, residual, retain, retained, retroactively, reverse, segment, settled, single, software, stated, store, strategy, succession, supplier, taxable, temporary, track, traditional, unaware, unconsolidated, unsecured, utilize, utilized, warehouse, Western, wholesale, written

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

FCPG similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of First China Pharmaceutical Group, Inc. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zhen Jiang Wang, Chief Executive Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

	i.	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

	ii.	The information contained in the Report fairly presents, in all material respects, the financial condition and results of

Date: August 20, 2012

/s/ Zhen Jiang Wang
Name: Zhen Jiang Wang
Title: Chief Executive Officer (Principal Executive Officer)